HEFT Repository

Measurement of Typhim Vi antibodies can be used to assess adaptive immunity in patients with immunodeficiency.

Evans, Caroline and Bateman, Elizabeth and Steven, Rachael and Ponsford, Mark and Cullinane, Alice and Shenton, Claire and Duthie, Gillian and Conlon, Chris and Jolles, Stephen and Huissoon, Aarnoud P and Longhurst, Hilary J and Rahman, Tasneem and Scott, Chris and Wallis, Gregg and Harding, Stephen and Parker, Antony R and Ferry, Berne L (2018) Measurement of Typhim Vi antibodies can be used to assess adaptive immunity in patients with immunodeficiency. Clinical and experimental immunology. ISSN 1365-2249. This article is accessible to all HEFT staff and students via NICE journals and databases http://www.nice.org.uk/about/what-we-do/evidence-services/journals-and-databases by using their HEFT Athens login IDs

Full text not available from this repository.
Official URL: http://onlinelibrary.wiley.com/doi/10.1111/cei.131...

Abstract

Vaccine specific antibody responses are essential in the diagnosis of antibody deficiencies. Responses to Pneumovax II are used to assess the response to polysaccharide antigens but interpretation may be complicated. Typhim Vi®, a polysaccharide vaccine for Salmonella typhoid fever, maybe an additional option for assessing humoral responses in patients suspected of having an immunodeficiency. Here we report a UK multicentre study describing the analytical and clinical performance of a Typhi Vi IgG ELISA calibrated to an affinity purified Typhi Vi IgG preparation. Intra- and inter-assay imprecision were low and the assay was linear between 7.4-574 U/mL (Slope=0.99-1.00; R2 >0.99). 71% of blood donors had undetectable Typhi Vi IgG antibody concentrations. Of those with antibody concentrations >7.4U/mL, the concentration range was 7.7-167 U/mL. In antibody deficient patients receiving antibody replacement therapy the median Typhi Vi IgG antibody concentrations were <25 U/mL. In vaccinated normal healthy volunteers, the median concentration post vaccination was 107 U/mL (range 31-542U/mL). 8/8 (100%) had post vaccination concentration increases of at least 3-fold and 6/8 (75%) of at least 10-fold. In an antibody deficient population (n=23), only 30% had post vaccination concentration increases of at least 3-fold and 10% of at least 10-fold. The antibody responses to Pneumovax II and Typhim Vi® correlated. We conclude that IgG responses to Typhim Vi® vaccination can be measured using the VaccZyme Salmonella typhi Vi IgG ELISA, and that measurement of these antibodies maybe a useful additional test to accompany Pneumovax II responses for the assessment of antibody deficiencies. This article is protected by copyright. All rights reserved.

Item Type: Article
Additional Information: This article is accessible to all HEFT staff and students via NICE journals and databases http://www.nice.org.uk/about/what-we-do/evidence-services/journals-and-databases by using their HEFT Athens login IDs
Subjects: QW Microbiology. Immunology
Divisions: Clinical Support > Pathology
Related URLs:
Depositing User: Mrs Yolande Brookes
Date Deposited: 02 Feb 2018 16:27
Last Modified: 02 Feb 2018 16:27
URI: http://www.repository.heartofengland.nhs.uk/id/eprint/1583

Actions (login required)

View Item View Item